Navigation Links
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Date:5/16/2013

regulated markets

• Next generation small molecule Erythropoiesis Stimulating Agents

• First generation EPO in less regulated markets (Central & South America;

Africa;

Asia;

Rest of the World)

• Darbepoietin biosimilars in less regulated markets

• Next generation biologic Erythropoiesis Stimulating Agents (ESA) in less regulated markets

 

 

 

2) G-CSF and GM-CSF

 

• 2012 Sales of Branded G-CSF Products in Regulated Markets

• 1st Generation Branded G-CSF Products in Regulated Markets

• Biosimilar 1st Generation G-CSF Products in Regulated Markets

• Next Generation Branded G-CSF Products in Regulated Markets

• Biosimilar Next Generation G-CSF Products in Regulated Markets

• 1st Generation G-CSF Products in Non-Regulated Markets: India

• 1st Generation G-CSF Products in Non-Regulated Markets: China & Taiwan

• 1st Generation G-CSF Products in Non-Regulated Markets – Korea

• 1st Generation G-CSF Products in Non-Regulated Markets – Latin America

• 1st Generation G-CSF Products in Non-Regulated Markets: Other Territories

• Next Generation G-CSF Products in Non-Regulated Markets

• 1st and Next Generation GM-CSF Products in Regulated Markets

• 1st and Next Generation GM-CSF Products in Non-Regulated Markets

 

3 ) Thrombopoiesis-Stimulating Agents (TPO; IL-11)

 

• Thrombopoietin receptor (TPO-R) activators

• Interleukin-11 (IL-11) receptor activators

• Small molecule TPO-R Agonists

• Corporate TPO/IL-1
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
6. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
7. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
10. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
11. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... (PRWEB) August 19, 2014 ... to raise $200,000 to fund a corporate lab ... , This development is a critical component ... of care to the implementation of personalized medicine ... of practicing medicine. , Indiegogo contributions will support ...
(Date:8/19/2014)... August 19, 2014 XenoTech announces ... and cost-effective metabolite production from bioactive small molecules. ... platform, the technology enables convenient and timely assessment ... to XenoTech’s Vice President of Commercial Operations, Christian ... assessing clinical risk can be measured directly by ...
(Date:8/19/2014)... 2012, the European Union (EU) mandated use of the ICH-recommended ... – responding to the increasing need to understand and manage ... many regions, the main objectives of the PBRER are to:, ... of new or emerging information on the risks of a ... potential benefits of a drug; and , Allow ...
(Date:8/19/2014)... August 19, 2014 Sales Horizons, a ... its online sales skills training course to ... , MedTech clinical staff spend the majority of their ... standalone medical center, or physician practice – providing support ... why stop there? Sales Horizons believes clinical staff are ...
Breaking Biology Technology:Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3
... (NSF) has awarded $6.5 million to the Center for Nanotechnology ... work regarding the societal aspects of nanotechnology for another five ... its first five-year award of $6.2 million to Arizona State ... of NSF,s initiative to support research and education on nanotechnology ...
... DIEGO, Oct. 14 Sequenom, Inc. (Nasdaq: ... a new clinical advisory board focusing on retinal ... will provide guidance to Sequenom and Sequenom Center ... of retinal care molecular diagnostics. (Logo: ...
... ... ... ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; ...
Cached Biology Technology:Arizona State University awarded $6.5 million to study nanotechnology and society 2Arizona State University awarded $6.5 million to study nanotechnology and society 3Sequenom Announces Formation of Ophthalmology Clinical Advisory Board 2Sequenom Announces Formation of Ophthalmology Clinical Advisory Board 3Sequenom Announces Formation of Ophthalmology Clinical Advisory Board 4Sequenom Announces Formation of Ophthalmology Clinical Advisory Board 5The World Market for Diabetes Treatments Now Available at ReportsandReports 2The World Market for Diabetes Treatments Now Available at ReportsandReports 3The World Market for Diabetes Treatments Now Available at ReportsandReports 4The World Market for Diabetes Treatments Now Available at ReportsandReports 5The World Market for Diabetes Treatments Now Available at ReportsandReports 6The World Market for Diabetes Treatments Now Available at ReportsandReports 7The World Market for Diabetes Treatments Now Available at ReportsandReports 8The World Market for Diabetes Treatments Now Available at ReportsandReports 9
(Date:8/20/2014)... who are poor experience higher cortisol levels in pregnancy ... the stress hormone, putting them at greater risk ... new research from the University of Colorado Denver. , ... Journal of Human Biology , is the first to ... the socioeconomic status of their mothers during pregnancy. , ...
(Date:8/20/2014)... for electronically manipulating the flight muscles of moths and ... those muscles. The work opens the door to the ... emergency response. , "In the big picture, we want ... moths for use in applications such as search and ... of electrical and computer engineering at NC State and ...
(Date:8/20/2014)... 2014  The second annual Biometrics UnPlugged Executive ... Tampa, Florida on September 15, 2014, ... Technology and Strategy at Samsung, and Philippe de ... of this year,s event is Mobility at the ... "Biometrics UnPlugged: Mobility at the Crossroads of Commerce ...
Breaking Biology News(10 mins):CU Denver researcher shows economic disparities impact infant health 2Research paves way for development of cyborg moth 'biobots' 2Biometrics UnPlugged: Mobility at the Crossroads of Commerce & Privacy to Feature Interactive Sessions with Samsung and Experian 2
... collaboration with colleagues from UC Berkeley and StrataGent Life ... pulsed microjet system engineered to deliver protein drugs into ... penetration injection systems cause. The research was published online ... Sciences. , The effort to create needle-free drug ...
... rise to a rare genetic disease, genetics researchers have ... broader role during human development, potentially in cases of ... of researchers identified two genes that contribute to Cornelia ... an estimated one in 10,000 children. The disease varies ...
... researchers from the National Human Genome Research Institute (NHGRI), ... identified a genetic variant that is a major contributor ... the April 6, 2007 issue of the journal Science. ... variant that accounts for differences in dog size is ...
Cached Biology News:Researchers design pulsed mircrojet system to deliver protein drugs without pain or bruising 2Gene found for rare disorder may reveal new pathway in mental retardation 2Researchers identify gene involved in dog size 2Researchers identify gene involved in dog size 3Researchers identify gene involved in dog size 4
... The ULS cDNA Synthesis and Labeling Kit ... hybridization experiments. First unmodified cDNA is made ... cDNA using an Oligo(dT) primer. Unlike other ... used in the reverse transcription reaction. This ...
... Dot Blot Kits overcome this limitation and ... a wide range in low-density protein array ... They are ideal for performing reverse-phase protein ... for the presence of low abundant antigens. ...
AC input: 50-60 Hz230 V...
... arraying proteins of interest with sensitive ... DiscoverLight Protein Array Kits allow for ... lysate or antibody in a low-density ... designed nitrocellulose membranes with a 384-grid ...
Biology Products: